We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

First-Ever Fully Implantable System Designed To Treat Chronic Migraine

By HospiMedica International staff writers
Posted on 02 Jan 2024
Print article
Image: The ShiraTronics device uses small electrical pulses to treat chronic migraines (Photo courtesy of ShiraTronics)
Image: The ShiraTronics device uses small electrical pulses to treat chronic migraines (Photo courtesy of ShiraTronics)

Globally acknowledged as a leading cause of disability, and particularly prevalent among pre-menopausal women, migraine pose a persistent health challenge. For nearly 2% of the global population, migraine intensifies into chronic episodes, plunging sufferers into a debilitating state with intense headaches, nausea, and light sensitivity for at least 15 days monthly, significantly diminishing their quality of life. While current treatments often provide inadequate relief, the demand for innovative and effective solutions remains high. Now, the first-ever fully implantable system for the head utilizing a minimally invasive approach has been developed to treat the debilitating symptoms faced by migraine patients.

ShiraTronics, Inc. (Minneapolis, MN, USA) is developing a Chronic Migraine System to specifically target the neural pathways involved in migraine episodes. This device, discreetly placed under the skin, employs neuromodulation therapy, which involves delivering small electrical impulses or 'stimulation' along the nerve pathways to alleviate the symptoms of chronic migraine. The system comprises thin leads connected to a compact stimulator device implanted under the skin. This stimulator delivers electrical pulses along the nerves involved in chronic migraine symptoms.

By delivering targeted electrical pulses, the ShiraTronics system is engineered to interrupt the pain signals associated with migraines. Patients can manage their treatment using a dedicated therapy application. This fully implantable, adjustable device represents a novel and potentially more efficacious treatment option for patients and healthcare providers. ShiraTronics has successfully completed the implantation of its Chronic Migraine System in the first six patients globally, representing a significant advancement in the field of neuromodulation.

"The achievement of this crucial milestone has validated all aspects of our procedure, system, and therapy settings,” said ShiraTronics Chief Executive Officer, Rob Binney. “Notably, it is encouraging that all six patients who completed the trial procedure opted for the permanent implantation of the ShiraTronics system. We are thankful for the invaluable guidance and contributions by our investigators to date and look forward to additional patient implants currently scheduled in the new year."

Related Links:
ShiraTronics, Inc.

Gold Member
Solid State Kv/Dose Multi-Sensor
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
EEG System

Print article


Critical Care

view channel
Image: The therapeutic tool can be used for children with kidney issues stemming from sepsis (Photo courtesy of 123RF)

New Device Treats Acute Kidney Injury from Sepsis

Sepsis, commonly referred to as "blood poisoning," can occur due to any infectious agent, triggering a systemic response by the body to combat the infection. This response involves the activation of circulating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.